FDA Recall Open, Classified

HardyCHROM CRE, selective and differential culture medium for antimicrobial susceptibility testing, Product Catalog No. G323

Recall: Z-2041-2025 · Initiated May 6, 2025

Recall

Recall Number
Z-2041-2025
Event Number
96843
Firm
Hardy Diagnostics
FEI Number
2022807
Product Code
JSO
Status
Open, Classified
Root Cause
Nonconforming Material/Component
Initiated
May 6, 2025
Posted
June 27, 2025
Address
1430 W McCoy Ln, Santa Maria, CA, 93455-1005

Description

HardyCHROM CRE, selective and differential culture medium for antimicrobial susceptibility testing, Product Catalog No. G323

Reason

Identified lots failed incoming quality control testing. Lots exhibited breakthrough growth of Klebsiella pneumoniae.

Action

On May 6, 2025, the firm began notifying customers via "URGENT Medical Device Recall Notification" letters. Customers were instructed to discard any remaining stock and to destroy it according to local regulations. If product was further distributed, notify the consignees who received the product. Please retain this letter or post the letter where the product is stored to ensure the users are aware of this defect. For replacements or credit, please contact the firm's Technical Services Department at (800) 266-2222, option 2 or via email at [email protected]. Replacements will be sent out at no-charge to your laboratory or a credit will be applied to your invoice upon request. If you have any questions, call 805-346-2766 or email: [email protected].

Distribution

US domestic distribution to the following states: AZ, CA, CO, FL, GA, IL, MD, ME, MI, MN, MO, NC, NE, NV, NY, PA, PR, TX, UT, VA, WI and WV.

Quantity

4300 ea